The US FDA appears to have had a change of heart when it comes to using social media to collect patient experience data.
The agency takes a more open and flexible view on the use of social media data collection methods in a new
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?